Correlation Between Day One and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and ProQR Therapeutics BV, you can compare the effects of market volatilities on Day One and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and ProQR Therapeutics.
Diversification Opportunities for Day One and ProQR Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Day and ProQR is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Day One i.e., Day One and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Day One and ProQR Therapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the ProQR Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 2.62 times less risky than ProQR Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The ProQR Therapeutics BV is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 206.00 in ProQR Therapeutics BV on November 3, 2024 and sell it today you would earn a total of 5.50 from holding ProQR Therapeutics BV or generate 2.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Day One Biopharmaceu |
| ProQR Therapeutics |
Day One and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and ProQR Therapeutics
The main advantage of trading using opposite Day One and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |